Nu Skin’s Insider Activity: A Quiet Buy and What It Signals

On March 11, 2026, owner Edwina D. Woodbury purchased 14 shares of Nu Skin’s Class A common stock through the company’s Deferred Compensation Plan, paying $7.31 per share—virtually the current market price. Although the trade is modest in size, it sits within a broader pattern of frequent, low‑volume transactions by Woodbury and other insiders, hinting at a strategy of gradual accumulation rather than large, market‑moving moves.

Why the Timing Matters

Nu Skin’s stock has been on a long‑term downtrend, down 28 % over the past year and 7 % in the week ending March 10. The company’s price‑earnings ratio of 2.3 and a market cap of just $359 M suggest that the shares are undervalued relative to earnings, especially given the firm’s recent focus on debt‑friendly expansion in the S‑REIT space. The buy through a dividend‑reinvestment plan is a subtle signal that Woodbury remains optimistic about Nu Skin’s ability to capitalize on lower borrowing costs to refinance its portfolio and fund growth initiatives.

Investor Takeaway

For investors, the trade is a “buy‑in‑confidence” cue. It shows that an insider is willing to add to her holdings amid a steep decline, implying a belief in a rebound. The trade’s small size keeps market impact low, but combined with the surge in other executives’ purchases—most notably CEO Ryan Napierski’s 282,353‑share buy on March 6—it paints a picture of top‑level conviction. Investors might view this as a green light to re‑evaluate the stock’s valuation relative to its earnings and growth prospects.

Woodbury’s Historical Profile

Woodbury’s transaction history reveals a pattern of disciplined, incremental buying. In December 2025, she purchased 10 shares at $10.35, and again on September 10, 2025, she bought 9 shares at $11.52. These purchases have consistently kept her shareholdings around 42,900 shares, with the most recent dividend‑reinvestment adding only 14 shares. Unlike some insiders who sell large blocks, Woodbury’s trades are small and regular, suggesting a long‑term holding strategy rather than a short‑term play.

Conclusion

The March 11 trade is a quiet affirmation of confidence in Nu Skin’s long‑term prospects. Coupled with other top executives’ purchases, it signals a belief that the company’s debt‑friendly expansion strategy will unlock value. While the trade itself is small, the cumulative insider activity provides a signal worth noting for investors who are weighing the company’s undervaluation against its growth potential.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-03-11WOODBURY EDWINA D ()Buy14.007.31Class A Common Stock